Sermorelin is a synthetic 29-amino acid peptide corresponding to the N-terminal fragment of human growth hormone-releasing hormone, designated GHRH(1-29). It is recognized as the shortest fully functional synthetic fragment of GHRH, retaining the complete biological activity of the native 44-amino acid hormone. Sermorelin acts by binding selectively to growth hormone-releasing hormone receptors (GHRHR) on anterior pituitary somatotroph cells, activating the adenylate cyclase-cAMP signaling cascade and stimulating physiologic pulsatile secretion of endogenous growth hormone. Because it works upstream at the pituitary rather than supplying exogenous growth hormone directly, sermorelin preserves negative feedback regulation through somatostatin. Its short plasma half-life, reported at roughly 11 to 12 minutes, makes it a widely used reference compound in neuroendocrine research, growth hormone axis studies, and somatotroph signaling investigations.
In stock
Free Shipping on orders over $200
Sermorelin is a reference tool compound for studying the GHRH receptor and its downstream signaling. In vitro work using anterior pituitary cultures has been used to characterize activation of the adenylate cyclase-cAMP cascade on binding to the GHRH receptor [1]. It does not act directly at the growth hormone receptor, which makes it a model for investigating receptor binding kinetics, signal transduction, and the architecture of pulsatile neuroendocrine secretion in laboratory systems [1, 4].
Sermorelin has been characterized in peer-reviewed literature as a tool for studying growth hormone secretory dynamics and the response properties of the somatotroph population [1]. It is referenced in research on hypothalamic-pituitary axis function and in comparative studies of growth hormone secretagogues [4].
Because endogenous GHRH signaling changes across the lifespan, sermorelin has been used as a model compound for investigating age-associated dynamics of the growth hormone axis [2]. Published literature has discussed it in the context of GHRH-receptor activity and feedback regulation within neuroendocrine research models [2].
Sermorelin has been employed in cell-based research examining GHRH receptor expression beyond the pituitary. Studies have used it as a ligand to probe receptor distribution and ligand-receptor interactions in cultured cell systems, providing a tool for structure-activity and receptor-specificity research [3].
The following citations are drawn from publications indexed on PubMed (pubmed.ncbi.nlm.nih.gov), PubMed Central (pmc.ncbi.nlm.nih.gov), and PubChem (pubchem.ncbi.nlm.nih.gov).
These products are for research use only and are not intended for human consumption, therapeutic use, or diagnostic purposes. All compounds described herein have not been approved by the FDA for human use. These products are strictly intended for in vitro laboratory research and analytical purposes when conducted by qualified research professionals in licensed facilities. Users are responsible for ensuring compliance with all applicable laws regarding purchase and use of these materials.
🎉 Thank you for your order!
Love our products?
Love our products? Join our Affiliate Program and earn 20% commission every time someone purchases through your referral link.
